> Detailanzeige

Salhofer-Polanyi, Sabine; Cetin, Hakan; Leutmezer, Fritz; Baumgartner, Anna; Blechinger, Stephan; Dal-Bianco, Assunta; Altmann, Patrick; Bajer-Kornek, Barbara; Rommer, Paulus; Guger, Michael; Leitner-Bohn, Doris; Reichardt, Berthold; Alasti, Farideh; Temsch, Wilhelm; Stamm, Tanja

Epidemiology of Multiple Sclerosis in Austria

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Epidemiology of Multiple Sclerosis in Austria
  • Beteiligte: Salhofer-Polanyi, Sabine; Cetin, Hakan; Leutmezer, Fritz; Baumgartner, Anna; Blechinger, Stephan; Dal-Bianco, Assunta; Altmann, Patrick; Bajer-Kornek, Barbara; Rommer, Paulus; Guger, Michael; Leitner-Bohn, Doris; Reichardt, Berthold; Alasti, Farideh; Temsch, Wilhelm; Stamm, Tanja
  • Erschienen: S. Karger AG, 2017
  • Erschienen in: Neuroepidemiology
  • Sprache: Englisch
  • DOI: 10.1159/000479696
  • ISSN: 0251-5350; 1423-0208
  • Schlagwörter: Neurology (clinical) ; Epidemiology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p>&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; To assess the incidence rate and prevalence ratio of multiple sclerosis (MS) in Austria. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; Hospital discharge diagnosis and MS-specific immunomodulatory treatment prescriptions from public health insurances, covering 98% of Austrian citizens with health insurance were used to extrapolate incidence and prevalence numbers based on the capture-recapture method. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; A total of 1,392,629 medication prescriptions and 40,956 hospitalizations were extracted from 2 data sources, leading to a total of 13,205 patients. The incidence rate and prevalence ratio of MS in Austria based on the capture-recapture method were 19.5/100,000 person-years (95% CI 14.3-24.7) and 158.9/100,000 (95% CI 141.2-175.9), respectively. Female to male ratio was 1.6 for incidence and 2.2 for prevalence. &lt;b&gt;&lt;i&gt;Conclusions:&lt;/i&gt;&lt;/b&gt; Incidence rates and prevalence ratios of MS in our study are within the upper range of comparable studies across many European countries as well as the United States.</jats:p>